当前位置: 首页 > 期刊 > 《中国当代医药》 > 2016年第36期 > 正文
编号:13069010
免疫制剂配合外用贝复济治疗复发性口腔溃疡的临床效果(4)
http://www.100md.com 2016年12月25日 中国当代医药2016年第36期
     [13]Emoto M,Shimizu T,Koike H,et al. Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling[J].Immunology,2010,129(1): 62-74.

    [14]Pedersen A,Klaosen B,Hougen HP,et al.T-lymphocyte subsets in recurrent aphthous ulceration[J].J Oral Pathol Med,1989,18(1):59-60.

    [15]Al-Samadi A,Kouri VP,Salem A,et al.IL-17C and its receptor IL-17RA/IL-17RE identify human oral epithelial cell as an inflammatory cell inrecurrent aphthous ulcer[J].J Oral Pathol Med,2014,43(2):117-124.

    [16]羅成.重组牛碱性成纤维细胞生长因子治疗复发性口腔溃疡临床观察[J].中国现代医生,2008,46(20):75-76.

    [17]黄敏,黄冬,郑泽荣.碱性成纤维细胞生长因子治疗复发性口腔溃疡165例[J].广东医学,2006,27(6):927-928.

    [18]Dalghous AM,Freysdottir J,Fortune F.Expression of cytotrines,chemokines,and chemokine receptors in oral ulcers of patients with Behcet′s disease(BD)and recurrent aphthous stomatitis is Th1-associated,although Th2-association is also observed in patients with BD[J].Scand J Rheumatol,2006,35(6):472-475.

    [19]巫志勇,吴建民.内外合治治疗复发性口腔溃疡的临床观察[J].中国当代医药,2014,21(20):135-136.

    [20]商继仲,张燕,刘占文.中药和左旋咪唑联合治疗复发性口腔溃疡的疗效观察[J].上海口腔医学,2010,19(3):247-249. (聂建芳)
上一页1 2 3 4